Stock Forecast
As of Fri Feb 26 2021 21:58:22 GMT+0000 (Coordinated Universal Time) shares of RUBY Rubius Therapeutics 21.88 percentage change in price since the previous day's close. Around 4087914 of 81182000 changed hand on the market. The Stock opened at 8.35 with high and low of 8.25 and 10.88 respectively. The price/earnings ratio is: - and earning per share is -2.08. The stock quoted a 52 week high and low of 3.35 and 15.99 respectively.
BOSTON (AI Forecast Terminal) Fri, Feb 26, '21 AI Forecast today took the forecast actions: In the context of stock price realization of RUBY Rubius Therapeutics is a decision making process between multiple investors each of which controls a subset of design variables and seeks to minimize its cost function subject to future forecast constraints. That is, investors act like players in a game; they cooperate to achieve a set of overall goals.Machine Learning utilizes multiple learning algorithms to obtain better predictive powers. In our research, we utilize machine learning to combine the results from the Neural Network and Support Vector Machines. Machine Learning based technical analysis (n+1y) for RUBY Rubius Therapeutics as below:
RUBY Rubius Therapeutics Credit Rating Overview
We rerate RUBY Rubius Therapeutics because If a breakdown of revenues by business line is not available, we apply a 188% risk weight to the highest annual revenue of the past three years. We use econometric methods for period (n+1y) simulate with Cross-Coupled Oscillators Spearman Correlation. Reference code is: 4315. Beta DRL value REG 18 Rational Demand Factor LD 6024.8538. To assess forecasted working capital outflows for companies with material intra-year working capital requirements (for example, companies in seasonal businesses), we use forecasted peak working capital outflows, per paragraph 32 of the liquidity criteria. For seasonal businesses, in many cases the annual projection might indicate a working capital inflow or neutral working capital, even though there could be material intra-quarter or inter-quarter outflows throughout the year. Credit Rating AI Process rely on primary sources of information: Sec Filings, Financial Statements, Credit Ratings, Semantic Signals. Take a look at Machine Learning section for Financial Deep Reinforcement Learning.
Oscillators are used for generating credit risk signals by using the semantic and financial signals. The value of the oscillators indicate the strength of trend. Using the correlation matrices, the risk map for RUBY Rubius Therapeutics as below:
Frequently Asked Questions
Q: What is RUBY Rubius Therapeutics stock symbol?A: RUBY Rubius Therapeutics stock referred as NASDAQ:RUBY
Q: What is RUBY Rubius Therapeutics stock price?
A: On share of RUBY Rubius Therapeutics stock can currently be purchased for approximately 9.78
Q: Do analysts recommend investors buy shares of RUBY Rubius Therapeutics ?
A: Machine Learning utilizes multiple learning algorithms to obtain better predictive powers. In our research, we utilize machine learning to combine the results from the Neural Network and Support Vector Machines. View Machine Learning based technical analysis for RUBY Rubius Therapeutics at daily forecast section
Q: What is the earning per share of RUBY Rubius Therapeutics ?
A: The earning per share of RUBY Rubius Therapeutics is -2.08
Q: What is the market capitalization of RUBY Rubius Therapeutics ?
A: The market capitalization of RUBY Rubius Therapeutics is 793554019
